By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
Schneider Shorts 5.05.2023 – Spanish Saudi Shills: a trilogy, state-of-the-art tools to cure diabetes, papermilling gang moves to new Elsevier journal, congrats on 1000 citations, with legitimate images, imaginary American co-authors, rapamycin longevity advice, catfish as COVID-19 origin, and finally, why German universities sponsor Hindawi.
“sadly, no-one could find any other evidence of existence for these festively-named individuals, who may well be Knock-Knock jokes that somehow gained sentience.” – Smut Clyde
Henry Markram deployed his Blue Brain supercomputer to crack COVID-19, thanks to Open Access and Frontiers. He now announces to use the technology to “address so many other diseases, accelerate science, and help save the planet from climate change”
Schneider Shorts 1.10.2021 – with antivaxxers big and small, Brazilian killers, Dutch research integrity, Russian science kakistocracy, the wonders of peer review, how COVID-19 miracle cures work, and a Twitter scandal of academic fraud which was too good to be true.
In 2019, MDPI published a Special Issue “Beyond Thirty Years of Research on Race Differences in Cognitive Ability”, one year later its owner Shu-Kun Lin expressed admiration for Trump and said “Black Lives Matter. White Lives Matter. All Lives Matter.”
Oncotarget, the somewhat controversial OA journal, switched from pretend-soliciting my services to threatening to sue me for defamation. Their lawyer writes my disrespect caused them financial damage.
The emails published here prove that EU Special Envoy for OA, Robert Jan Smits, received constant counselling from Frontiers CEO Kamila Markram when designing Plan S. It seems, Frontiers and Smits share exactly same vision for the future of scholarly publishing.
Lynn Kamerlin, Bas de Bruin and their colleagues have been the most vocal critics of Plan S from the very beginning, braving continuous opposition from certain OA leaders. Now that final Plan S guidelines were released, the chemists publish this Open Letter expressing their worry about a possible dystopian OA future.
A former Karolinska researcher is subject of research misconduct investigation, for forwarding to university OA publishing bills for her past research there. To save €3k, no trick is too dirty for Karolinska Institutet.
Bremen rector Bernd Scholz-Reiter previously explained his predatory publishing and self-plagiarism as a personal crusade for Open Access. Now a closed access conference paper he coauthored was declared by his university as definitely not plagiarised.
For Better Science